Antidote to synthetic cannabis intoxication could be found in slimming drug
Queen Mary University of London News Oct 18, 2017
Early research from Queen Mary University of London (QMUL) has potentially found an antidote that can rapidly stop the intoxicating effects of cannabis and synthetic cannabinoids.
Synthetic cannabinoids, such as ÂSpice and ÂBlack MambaÂ, are becoming an increasing problem, especially with young people and within the homeless and prison populations, due to their low cost and odourless properties. Their enhanced strength compared to cannabis is leading to an increasing number of severe adverse reactions and deaths.
The study, published in the British Journal of Pharmacology, looked at mice that were experiencing the effects of synthetic cannabinoid intoxication, to see the effects of treating them with a molecule known as AM251.
AM251 blocked the action of the synthetic cannabinoid on one of the brain receptors and led to a loss of the cannabinoid-related behavioural effects within a few minutes. This included a significant loss of sedation within 20 minutes.
The researchers say that the most rapid way to develop an antidote would be to re-develop one of the slimming drugs, known as rimonabant, which also blocks the cannabinoid system on which cannabis acts.
Lead author Professor David Baker from QMULÂs Blizard Institute said: ÂSynthetic cannabis can get people very intoxicated and there are an increasing number of deaths reported. This could be due to cannabinoids making your heart race, leading to heart issues. It can also cause seizures.
ÂWhat we found was that we could turn off the Âhigh within a few minutes. Although itÂs fairly common to be able to block the action of a drug from working in the first place, itÂs quite surprising that we could use this molecule to turn off the Âhigh once the intoxicating effects had already started.Â
The paper is titled, ÂAntidote to cannabinoid intoxication: the CB1 receptor inverse agonist, AM251, reverses hypothermic effects of the CB1 receptor agonist, CB-13, in mice.Â
Go to Original
Synthetic cannabinoids, such as ÂSpice and ÂBlack MambaÂ, are becoming an increasing problem, especially with young people and within the homeless and prison populations, due to their low cost and odourless properties. Their enhanced strength compared to cannabis is leading to an increasing number of severe adverse reactions and deaths.
The study, published in the British Journal of Pharmacology, looked at mice that were experiencing the effects of synthetic cannabinoid intoxication, to see the effects of treating them with a molecule known as AM251.
AM251 blocked the action of the synthetic cannabinoid on one of the brain receptors and led to a loss of the cannabinoid-related behavioural effects within a few minutes. This included a significant loss of sedation within 20 minutes.
The researchers say that the most rapid way to develop an antidote would be to re-develop one of the slimming drugs, known as rimonabant, which also blocks the cannabinoid system on which cannabis acts.
Lead author Professor David Baker from QMULÂs Blizard Institute said: ÂSynthetic cannabis can get people very intoxicated and there are an increasing number of deaths reported. This could be due to cannabinoids making your heart race, leading to heart issues. It can also cause seizures.
ÂWhat we found was that we could turn off the Âhigh within a few minutes. Although itÂs fairly common to be able to block the action of a drug from working in the first place, itÂs quite surprising that we could use this molecule to turn off the Âhigh once the intoxicating effects had already started.Â
The paper is titled, ÂAntidote to cannabinoid intoxication: the CB1 receptor inverse agonist, AM251, reverses hypothermic effects of the CB1 receptor agonist, CB-13, in mice.Â
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries